Paediatrics: genetic insights and long-term follow-up.
Forsyth
Rob
R
School of Clinical Medical Sciences, Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK. r.j.forsyth@newcastle.ac.uk
D000927:Anticonvulsants / Q000009:adverse effects; D001321:Autistic Disorder / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D002648:Child; D006233:Persons with Disabilities; D004831:Epilepsies, Myoclonic / Q000235:genetics* / Q000628:therapy; D005838:Genotype; D006801:Humans; D007223:Infant; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects; D009154:Mutation; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000235:genetics*; D010641:Phenotype; D015222:Sodium Channels / Q000235:genetics*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics*
D000927:Anticonvulsants; D022542:Measles-Mumps-Rubella Vaccine; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; C568242:SCN1A protein, human; D015222:Sodium Channels; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases